Clinical Kidney Journal | 2021
Kidney transplantation improving cardiopulmonary exercise responses: still some way to go before conclusive evidence
Abstract
In an important recent study, Lim et al. [1] first used cardiopulmonary exercise testing (CPET) to assess cardiovascular responses in 81 chronic kidney disease (CKD) Stage 5 patients before and after kidney transplantation, 81 CKD Stage 5 patients who remained wait-listed and 87 hypertensive patients, who served as controls. At baseline, mean maximum oxygen consumption (VO2max) was significantly lower in the two CKD groups than in controls (20.7 6 5.8, 18.9 6 4.7 and 24.9 6 7.1 mL/min/kg, respectively). During 1-year follow-up, VO2max significantly increased in transplanted patients to 22.5 6 6.3 and decreased in wait-listed patients to 17.7 6 4.1 mL/min/kg, without changing in controls. The authors concluded that kidney transplantation improves cardiovascular functional reserve after 1 year. Although the study findings are novel, there are several issues that may limit its conclusions. The authors report a ‘prospective, nonrandomized, 3-arm, controlled, cohort study’, but they use no matching process to have balanced groups, resulting in major baseline differences in parameters affecting cardiovascular profile. The 7-year age difference and 7-month dialysis vintage difference between the kidney transplant and haemodialysis groups make them rather non-comparable. The hypertensive group has a 10-year age difference from transplanted patients, together with 0% prevalence of diabetes and cardiovascular disease, and much higher average blood pressure than both CKD Stage 5 groups, findings incompatible with a randomly selected group. Most importantly, the choice of hypertensives as controls is, in principal, not justified, due to major differences in the prevalence of traditional and CKD-specific risk factors between CKD Stage 5 and the average hypertensive. Differences in phosphorus, parathormone, albumin, haemoglobin and high sensitivity Creactive protein levels are large; all these are independently associated with increased cardiovascular risk [2]. Assessing this issue with statistical adjustment for 10 variables in 80-subject groups is not adequate. The study could be more valid with a blinded matching for age, sex and dialysis vintage for CKD Stage 5 groups, as other studies in end-stage renal disease [3], and a similar process to add a more appropriate control group (i.e. CKD Stage 3b–4 patients). Furthermore, a major effect of haemoglobin changes specifically on CPET parameters is highly likely; a haemoglobin difference of 3 g/dL results in 19% reduction in blood oxygencarrying capacity and relevant peak VO2 decrease at any given cardiac output [4]. In low arterial O2, there is a rapid decrease of O2 diffusion gradient from blood to mitochondria, resulting in early anaerobic metabolism and low oxygen uptake at anaerobic threshold (VO2AT). In transplant patients, haemoglobin change was not correlated with VO2max improvement, but the relevant P-value was 0.05 and haemoglobin levels at study end are not reported. Several limitations exist also regarding CPET analysis [5]. Normal expected VO2max and VO2AT values are derived from equations using gender, age, weight and height; thus, using the %predicted values for between-group